AMRN
Amarin Corporation plcNASDAQHealthcare$14.74+0.68%ClosedMarket Cap: $304.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
13.26
P/S
1.65
EV/EBITDA
-10.94
DCF Value
$0.33
FCF Yield
2.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.7%
Operating Margin
-12.7%
Net Margin
-21.1%
ROE
-8.4%
ROA
-5.8%
ROIC
-4.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $19.4M | 119.2% | $20.5M | $-1.2M | $-0.00 | — |
| FY 2025 | $182.8M | 66.1% | $-13.9M | $-38.8M | $-0.09 | — |
| Q3 2025 | $49.7M | 44.7% | $-11.1M | $-7.7M | $-0.37 | — |
| Q2 2025 | $72.7M | 69.2% | $-16.0M | $-14.1M | $-0.68 | — |
| Q1 2025 | $42.0M | 59.8% | $-16.8M | $-15.7M | $-0.76 | — |
| Q4 2024 | $62.3M | -15.4% | $-52.5M | $-48.6M | $-2.37 | — |
| FY 2024 | $228.6M | 35.6% | $-91.8M | $-82.2M | $-4.00 | — |
| Q3 2024 | $42.3M | 38.5% | $-25.2M | $-25.1M | $-1.22 | — |
| Q2 2024 | $67.6M | 62.2% | $-524.6K | $1.5M | $0.07 | — |
| Q1 2024 | $56.5M | 56.4% | $-13.6M | $-10.0M | $-0.49 | — |
| Q4 2023 | $75.4M | 59.4% | $-4.6M | $-5.8M | $-0.29 | — |
| FY 2023 | $306.9M | 53.9% | $-67.6M | $-59.1M | $-3.00 | — |